Clinical Trial Update: Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND) [Phase 3]

View source ↗

Summary

Phase 3 BEYOND trial evaluating Follitropin delta in long GnRH agonist and GnRH antagonist protocols has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Follitropin Delta (follicle-stimulating hormone delta)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Infertility, Female | Phase 3 | Status: COMPLETED | Results posted: 2024-05-13